Reanalysis of Pargluva data questions safety
Researchers in last week’s Journal of the American Medical Association wrote that Bristol-Myers Squibb/Merck’s Pargluva appeared to double the risk ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.